CPT Codes For Introduction Or Removal Procedures On The Integumentary System
Below is a list summarizing the CPT codes for introduction or removal procedures on the integumentary system.
CPT Code 11900
CPT 11900 describes the injection of up to seven intralesional lesions.
CPT Code 11901
CPT 11901 describes an injection intralesional for more than seven lesions.
CPT Code 11920
CPT 11920 describes the tattooing, intradermal introduction of insoluble opaque pigments to correct skin color defects, including micropigmentation, with a surface area of 6.0 sq cm or less.
CPT Code 11921
CPT 11921 describes the tattooing, intradermal introduction of insoluble opaque pigments to correct skin color defects, including micropigmentation, with a surface area of 6.1 to 20.0 sq cm.
CPT Code 11950
CPT 11950 describes subcutaneous injection of filling material (e.g., collagen) in 1 cc or less.
CPT Code 11951
CPT 11951 describes subcutaneous injection of filling material (e.g., collagen) with a 1.1 to 5.0 cc volume.
CPT Code 11952
CPT 11952 describes subcutaneous injection of filling material (e.g., collagen) in a range of 5.1 to 10.0 cc.
CPT Code 11954
CPT 11954 describes subcutaneous injection of filling material (e.g., collagen) over 10.0 cc.
CPT Code 11960
CPT 11960 describes the insertion of a tissue expander(s) other than the breast and subsequent expansion.
CPT Code 11970
CPT 11970 describes the replacement of a tissue expander with a permanent implant.
CPT Code 11971
CPT 11971 describes the removal of a tissue expander without the insertion of an implant.
CPT Code 11976
CPT 11976 describes the removal of implantable contraceptive capsules.
CPT Code 11980
CPT 11980 describes the implantation of estradiol and/or testosterone pellets beneath the skin.
CPT Code 11981
CPT 11981 describes the insertion of a drug-delivery implant, such as a bioresorbable, biodegradable, or non-biodegradable implant.
CPT Code 11982
CPT 11982 describes the removal of a non-biodegradable drug delivery implant.
CPT Code 11983
CPT 11983 describes removal with reinsertion of a non-biodegradable drug delivery implant.